研究文章
血清学分型和药敏模式大肠杆菌分离菌尿路感染在三级保健医院在儿科人口
|
| 大肠杆菌() |
电阻(%) |
Typable菌株() |
Nontypable菌株() |
|
| 氨苄青霉素 |
73例(97.3%) |
33 (100%) |
40 (95.2%) |
| 庆大霉素 |
35 (46.7%) |
15 (45.4%) |
20 (47.6%) |
| 阿米卡星 |
12 (16%) |
6 (18.2%) |
6 (14.3%) |
| 阿莫西林/ clavulanate |
72例(96%) |
32 (97%) |
40 (95.2%) |
| 功效 |
63例(84%) |
26 (78.8%) |
37 (88.1%) |
| 呋喃妥英 |
4 (5.3%) |
2 (6%) |
2 (4.7%) |
| 萘啶酸 |
74例(98.7%) |
33 (100%) |
41 (97.6%) |
| 头孢噻肟 |
61例(81.3%) |
30 (90.9%) |
31 (73.8%) |
| 哌拉西林/ tazobactam |
10 (13.3%) |
5 (15.1%) |
5 (11.9%) |
| Meropenem |
1 (1.3%) |
1 (3%) |
0 (0%) |
|
ESBL |
36 (48%) |
19 (57.6%) |
17 (40.5%) |
|
|
ESBL:扩展光谱β内酰胺酶。
|
